A detailed history of Governors Lane LP transactions in Catalent, Inc. stock. As of the latest transaction made, Governors Lane LP holds 272,400 shares of CTLT stock, worth $16.1 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
272,400
Previous 315,600 13.69%
Holding current value
$16.1 Million
Previous $17.7 Million 7.03%
% of portfolio
1.37%
Previous 1.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $2.43 Million - $2.63 Million
-43,200 Reduced 13.69%
272,400 $16.5 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $16.9 Million - $18 Million
315,600 New
315,600 $17.7 Million
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $2.23 Million - $2.54 Million
50,500 Added 86.32%
109,000 $4.96 Million
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $1.86 Million - $3.93 Million
58,500 New
58,500 $2.54 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Governors Lane LP Portfolio

Follow Governors Lane LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Governors Lane LP, based on Form 13F filings with the SEC.

News

Stay updated on Governors Lane LP with notifications on news.